Noor Atatreh
TitleCited byYear
In silico screening and biological evaluation of inhibitors of Src-SH3 domain interaction with a proline-rich ligand
N Atatreh, C Stojkoski, P Smith, GW Booker, C Dive, AD Frenkel, ...
Bioorganic & medicinal chemistry letters 18 (3), 1217-1222, 2008
232008
Effects of antihistamines on the function of human α7-nicotinic acetylcholine receptors
B Sadek, SS Khanian, A Ashoor, T Prytkova, MA Ghattas, N Atatreh, ...
European journal of pharmacology 746, 308-316, 2015
172015
Druggability analysis and classification of protein tyrosine phosphatase active sites
MA Ghattas, N Raslan, A Sadeq, M Al Sorkhy, N Atatreh
Drug design, development and therapy 10, 3197, 2016
112016
Protein tyrosine phosphatases: Ligand interaction analysis and optimisation of virtual screening
MA Ghattas, N Atatreh, EV Bichenkova, RA Bryce
Journal of Molecular Graphics and Modelling 52, 114-123, 2014
102014
Antibacterial activity and mechanism of action of the benzazole acrylonitrile-based compounds: in vitro, spectroscopic, and docking studies
SS AlNeyadi, AA Salem, MA Ghattas, N Atatreh, IM Abdou
European journal of medicinal chemistry 136, 270-282, 2017
92017
Analysis of Enoyl‐acyl carrier protein reductase structure and interactions yields an efficient virtual screening approach and suggests a potential allosteric site
MA Ghattas, RA Mansour, N Atatreh, RA Bryce
Chemical biology & drug design 87 (1), 131-142, 2016
92016
Difluoro analogue of UCS15A triggers activation of exogenously expressed c-Src in HCT 116 human colorectal carcinoma cells
N Atatreh, J Barraclough, A Welman, C Cawthorne, RA Bryce, C Dive, ...
Journal of enzyme inhibition and medicinal chemistry 22 (5), 638-646, 2007
62007
Identification of new inhibitors of Mdm2–p53 interaction via pharmacophore and structure-based virtual screening
N Atatreh, MA Ghattas, SK Bardaweel, S Al Rawashdeh, M Al Sorkhy
Drug design, development and therapy 12, 3741, 2018
52018
Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo [3, 4-d] pyrimidine compounds
N Atatreh, AM Youssef, MA Ghattas, M Al Sorkhy, S Alrawashdeh, ...
Bioorganic chemistry 86, 393-400, 2019
22019
Computer-aided discovery of antimicrobial agents as potential enoyl acyl carrier protein reductase inhibitors
MA Ghattas, NA Eissa, SK Bardaweel, AA Mellal, N Atatreh
Tropical Journal of Pharmaceutical Research 16 (2), 397-405, 2017
22017
Comparative molecular dynamics simulation of aggregating and non‐aggregating inhibitor solutions: understanding the molecular basis of promiscuity
MA Ghattas, RA Bryce, S Al Rawashdah, N Atatreh, WA Zalloum
ChemMedChem 13 (6), 500-506, 2018
12018
Isoindolinone based inhibitors of the MDM2-p53 protein-protein interaction
SJ Kemp, IR Hardcastle, SU Ahmed, NA Atatreh, P Barrett, JA Endicott, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 230, U2735-U2736, 2005
12005
Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol
S Al Rawashdah, A Hamrouni, B Sadek, R Amer, M Metwaly, N Atatreh, ...
Journal of Molecular Graphics and Modelling 92, 44-54, 2019
2019
Structure‐based drug design and in vitro testing reveal new inhibitors of enoyl‐acyl carrier protein reductases
MA Ghattas, NA Eissa, F Tessaro, R Perozzo, L Scapozza, D Obaid, ...
Chemical biology & drug design, 2019
2019
Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening
N Atatreh, S Al Rawashdah, SS Al Neyadi, SM Abuhamdah, MA Ghattas
Journal of enzyme inhibition and medicinal chemistry 34 (1), 1373-1379, 2019
2019
Enzyme adsorption by drug aggregates: probing the molecular basis of inhibitor promiscuity using molecular dynamics simulations
M Ghattas, N Atatreh, S Alrawashdeh, R Bryce
EUROPEAN JOURNAL OF CANCER 103, E68-E69, 2018
2018
The discovery of potential CDK2-Spy1 inhibitors via structure-based drug design
N Atatreh, M Al Sorkhy, S Al Rawashdah, M Ghattas
EUROPEAN JOURNAL OF CANCER 103, E93-E94, 2018
2018
In silico design of new MPS1 inhibitors via a validated structure-based virtual screening approach
M Ghattas, MA Sorkhy, N Atatreh
Der Pharma Chemica 8 (2), 365-374, 2016
2016
Molecular modeling approach for exploring the MDM2 active site for the discovery of new P53-MDM2 inhibitors
N Atatreh, R Mansour, M Ghattas
In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular …, 2015
2015
Druggability assessment of protein tyrosine phosphatase binding site
M Ghattas, R Noor, S Asil, N Atatreh
In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular …, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–20